PER
Click for more information
2.63% 7.8¢ percheron therapeutics limited

Ann: Chief Executive Officer and Managing Director Appointment, page-36

  1. samfiodiving
    4,103 Posts.
    lightbulb Created with Sketch. 1866
    clock Created with Sketch.
    08/05/23
    14:33
    Post #: 67659637

    From Sept 22 Ann

    These revised clinical plans have substantially reduced the Company's budgeted trial costs, and with the expected additional R&D tax incentive rebates, the Company now estimates that it can fund both the Company and the trial into 4Q’23.
    ANP Price at posting: 7.3¢ Sentiment: Hold Disclosure: Held
    Likes Created with Sketch. 10  Upvote
    lightbulb Created with Sketch. 1  Great analysis
    Stroke 3 Created with Sketch. Comments Created with Sketch. Reply

  2. Top Stories

 

Featured News

NEWS Is oil undervalued?
right-arrow Created with Sketch.
BOE Uranium prices on the NYMEX are stable, but ASX uranium stocks are sinking on Friday. The answer lies in Kazakhstan
right-arrow Created with Sketch.
MGU Collaboration in a green (steel) future the focus for Magnum and Saudi partners
right-arrow Created with Sketch.
NEWS Week 31 Wrap: JORC rules to get tougher; RBA rate hike chance 50/50; US Fed Sept cut still the quo
right-arrow Created with Sketch.
NXG Cost blow-out for Rook I uranium project sees share plummet for NexGen
right-arrow Created with Sketch.
watchlist Created with Sketch. Add PER (ASX) to my watchlist
(20min delay)
Last
7.8¢ 		Change
0.002(2.63%) 		Mkt cap ! $70.32M
Open High Low Value Volume
7.9¢ 7.9¢ 7.8¢ $5.66K 72.22K

Buyers (Bids)

No. Vol. Price($)
1 15000 7.7¢
 

Sellers (Offers)

Price($) Vol. No.
7.9¢ 185244 3
View Market Depth
Last trade - 10.55am 09/08/2024 (20 minute delay) ?
PER (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.